Is Kenvue’s (KVUE) Profitability Strengthening Despite Softer Sales Altering The Investment Case For Kenvue (KVUE)?

Simply Wall St

Wed, February 18, 2026 at 3:10 PM GMT+9 3 min read

In this article:

KVUE

-1.55%

Kenvue Inc. has reported its fourth-quarter 2025 results, with sales rising to US$3,780 million and net income reaching US$330 million, while full‑year sales eased to US$15.12 billion but net income increased to US$1.47 billion.

The stronger earnings and higher earnings per share compared with the prior year, despite slightly lower annual sales, highlight Kenvue’s recent profitability improvement.

We’ll now examine how this earnings outperformance, particularly the rise in full‑year net income, may influence Kenvue’s broader investment narrative.

Uncover the next big thing with 31 elite penny stocks that balance risk and reward.

Kenvue Investment Narrative Recap

To own Kenvue, you need to believe in its core consumer health brands, improving profitability, and the company’s ability to simplify operations while adapting to digital channels. The latest results, with higher full year net income despite slightly softer sales, support the profitability leg of that thesis, but do not materially change the near term focus on integrating operational improvements and managing execution risk around ongoing corporate changes.

The recent fourth quarter and full year 2025 earnings announcement is the key update here, as it shows net income rising to US$330 million in Q4 and US$1.47 billion for the year, while sales were broadly flat. This profit uplift sits alongside Kenvue’s ongoing leadership transitions and pending Kimberly Clark transaction, which together keep execution and organizational stability squarely in focus as investors think about what drives results from here.

Yet with board turnover, a CFO transition, and a pending merger all in motion, investors should be aware of how leadership change could affect…

Read the full narrative on Kenvue (it’s free!)

Kenvue’s narrative projects $16.3 billion revenue and $2.1 billion earnings by 2028. This implies 2.6% yearly revenue growth and an earnings increase of about $0.7 billion from $1.4 billion today.

Uncover how Kenvue’s forecasts yield a $18.92 fair value, a 3% upside to its current price.

Exploring Other Perspectives

KVUE 1-Year Stock Price Chart

Four members of the Simply Wall St Community currently value Kenvue between US$18.92 and US$29.77 per share, highlighting very different expectations. You can compare those views with the recent earnings driven profitability improvement and decide what that might mean for Kenvue’s ability to manage execution risk over time.

Explore 4 other fair value estimates on Kenvue - why the stock might be worth as much as 62% more than the current price!

Form Your Own Verdict

Don’t just follow the ticker - dig into the data and build a conviction that’s truly your own.

Story Continues  

A great starting point for your Kenvue research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Our free Kenvue research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Kenvue's overall financial health at a glance.

Searching For A Fresh Perspective?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.

Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include KVUE.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info